Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 13.74% ...

Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on ...

Cargo Therapeutics, a Bay Area biotech firm, is laying off half its staff after having to shut down a promising drug ...

Among significant research news last week, US biotech Allakos reported that it was dropping development of its urticaria ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...

Release Jan. 27 - Allakos: The biotech is dropping its lead candidate after a phase 1 data drop in hives and is laying off 75% of its employees as it explores strategic alternatives. Story Jan. 22 ...

After hours: January 31 at 7:57:45 PM EST ...

Pre-Market: 8:50:47 am GMT-5 ...